|
[1]Chalasani N, Fontana RJ, Bonkovsky HL, et al.Causes, clinical features, and outcomes from a prospective study ofdrug-induced liver injury in the united states[J].Gastroen-terology, 2008, 135 (6) :1924-1934.
|
|
[2]Hoofnagle JH.Drug-induced liver injury network (DILIN) [J].Hepatology, 2004, 40 (4) :773.
|
|
[3]姚光弼.临床肝脏病学[M].上海:上海科技出版社, 2004.
|
|
[4]Goldstein GB, Lam KC, Mistilis SP.Drug-induced active chro-nic hepatitis[J].Am J Dig Dis, 1973, 18 (3) :177-184.
|
|
[5]Maddrey WC, Boitnott JK.Drug-induced chronic liver dis-ease[J].Gastroenterology, 1977, 72 (6) :1348-1353.
|
|
[6]Seeff LB.Drug-induced chronic liver disease, with empha-sis on chronic active hepatitis[J].Semin Liver Dis, 1981, 1 (2) :104-115.
|
|
[7]尤金R.希夫, 迈克尔F.索雷尔, 威利斯C.希夫肝脏病学 (下册) [M].马德里, 黄志强, 译.第九版.北京:化学工业出版社, 2006:999-1013.
|
|
[8]杨建轩, 闫惠平, 檀玉芬, 等.药物性肝损伤患者的自身抗体分析[J].临床荟萃, 2008, 23 (14) :992-995.
|
|
[9]Albert J, Czaja AJ, Gary L, et al.Autoantibodies in the diag-nosis and management of liver disease[J].J Clin Gastroen-terol, 2003, 37 (4) :315-329.
|
|
[10]陈成伟.药物性肝病的发病机制及诊治[J].肝脏, 2007, 12 (4) :297-302.
|
|
[11]Bjornsson E, Talwalkar J, Treeprasertsuk S, et al.Drug-in-duced autoimmune hepatitis:clinical characteristics andprognosis[J].Hepatology, 2010, 51 (6) :2040-2048.
|
|
[12]Lucena MI, Kaplowitz N, Hallal H, et al.Recurrent drug-in-duced liver injury (DILI) with different drugs in the SpanishRegistry.The dilemma of the relationship to autoimmunehepatitis[J].J Hepatol, 2011, 55 (4) :820-827.
|
|
[13]Lucena MI, Andrade RJ, Kaplowitz N, et al.Phenotypic charac-terization of idiosyncratic drug induced liver injury:the influenceof age and sex[J].Hepatology, 2009, 49 (6) :2001-2009.
|
|
[14]Fontana RJ, Seeff LB, Andrade RJ, et al.Standardization ofnomenclature and causality assessment in drug-induced liv-er injury:summary of a clinical research workshop[J].Hep-atology, 2010, 52 (2) :730-742.
|
|
[15]Elkayam O, Yaron M, Caspi D.Minocycline-induced autoim-mune syndromes:an overview[J].Semin Arthritis Rheum, 1999, 28 (6) :392-397.
|
|
[16]Stricker BH, Blok AP, Claas FH, et al.Hepatic injury associ-ated with the use of nitrofurans:a clinicopathological study of52 reported cases[J].Hepatology, 1988, 8 (3) :599-606.
|
|
[17]Lewis JH, Zimmerman HJ.Drug-induced autoimmune liverdisease[M]//Krawitt EL, Wiesner RH, Nishioka K, eds.Autoimmune Liver Diseases.2nd ed.Amsterdam:Elsevier, 1998:627-649.
|
|
[18]Liu ZX, Kaplowitz N.Immune-mediated drug-induced liverdisease[J].Clin Liver Dis, 2002, 6 (3) :755-774.
|
|
[19]Watkins PB, Seeff LB.Drug-induced liver injury:summaryof a single topic clinical research conference[J].Hepatolo-gy, 2006, 43 (3) :618-631.
|
|
[20]Bjornsson E, Davidsdottir L.The long-term follow-up af-ter idiosyncratic drug-induced liver injury with jaundice[J].J Hepatol, 2009, 50 (3) :511-517.
|
|
[21]Manns MP, Czaja AJ, Gorham JD, et al.Diagnosis and management of autoimmune hepatitis[J].Hepatology, 2010, 51 (6) :2193-2213.
|
|
[22]Czaja AJ.Current and future treatments of autoimmune hep-atitis[J].Expert Rev Gastroenterol Hepatol, 2009, 3 (3) :269-291.
|
|
[23]Czaja AJ.Rapidity of treatment response and outcome in type1autoimmune hepatitis[J].J Hepatol, 2009, 51 (1) :161-167.
|
|
[24]Montano-Loza AJ, Carpenter HA, Czaja AJ.Improving the endpoint of corticosteroid therapy in type1autoimmune hep-atitis to reduce the frequency of relapse[J].Am J Gastroen-terol, 2007, 102 (5) :1005-1012.
|
|
[25]Czaja AJ.Drug-induced autoimmune-like hepatitis[J].Dig Dis Sci, 2011, 56 (4) :958-976.
|
|
[26]Czaja AJ.Autoimmune hepatitis.Part B:diagnosis[J].Ex-pert RevGastroenterol Hepatol, 2007, 1 (1) :129-143.
|
|
[27]Desmet VJ, Gerber M, Hoofnagle JH, et al.Classification of chronic hepatitis:diagnosis, grading and staging[J].Hepa-tology, 1994, 19 (6) :1513-1520.
|
|
[28]Czaja AJ, Carpenter HA, Santrach PJ, et al.Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States[J].J Hepatol, 1993, 18 (3) :342-352.
|
|
[29]Czaja AJ.Extrahepatic immunologic features of chronic viral hepatitis[J].Dig Dis, 1997, 15 (3) :125-144.
|
|
[30]Czaja AJ, Carpenter HA.Histological findings in chronic hep-atitis C with autoimmune features[J].Hepatology, 1997, 26 (2) :459-466.
|
|
[31]刘燕敏, 闫惠平, 韩莹, 等.急性及慢性药物性肝损害患者肝功能及自身抗体检测的临床意义[J].中华肝脏病杂志, 2010, 18 (1) :37-40.
|
PDF下载 ( 1146 KB)
本文二维码
下载:
